Triple Therapy with Budesonide/Glycopyrrolate/Formoterol Fumarate Improves Inspiratory Capacity in Patients with Asthma-Chronic Obstructive Pulmonary Disease Overlap.

Yoshihisa IshiuraMasaki FujimuraNoriyuki OhkuraJohsuke HaraKazuo KasaharaNobuyasu IshiiYusuke SawaiToshiki ShimizuTakeshi TamakiShosaku Nomura

Published in: International journal of chronic obstructive pulmonary disease (2020)

The present pilot study showed that triple therapy with BUD/GLY/FORM results in an improvement in lung function parameters including IC, indicating the potential value of triple therapy as standard treatment for ACO.

Keyphrases

lung function
chronic obstructive pulmonary disease
cystic fibrosis
air pollution
risk assessment
mesenchymal stem cells
combination therapy